Nephros Earnings Estimate

NEPH
 Stock
  

USD 1.74  0.04  2.25%   

Many public companies, such as Nephros, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Nephros' earnings estimates, investors can diagnose different trends across Nephros' analyst sentiment over time as well as compare current estimates against different timeframes.
Nephros is projected to generate -0.4 in earnings per share on the 31st of December 2021. Nephros earnings estimates module stress-tests analyst consensus about projected Nephros EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Additionally, see Stocks Correlation.
  

Nephros Earnings Estimation Breakdown

Calculation of earning per share of Nephros is based on official Zacks consensus of 1 analysts regarding Nephros future annual earnings. Given the historical accuracy of 73.33%, the future earnings per share of Nephros is estimated to be -0.4 with the lowest and highest values of -0.4 and -0.4, respectively. Please note that this consensus of annual earnings estimates for Nephros is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS -0.55
-0.4
Lowest
Expected EPS -0.4
-0.4
Highest

Nephros Earnings Projection Consensus

Suppose the current estimates of Nephros' value are higher than the current market price of the Nephros stock. In this case, investors may conclude that Nephros is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Nephros' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

1

73.33%

-0.549

-0.4

Nephros Earnings per Share Projection vs Actual

Actual Earning per Share of Nephros refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Nephros predict the company's earnings will be in the future. The higher the earnings per share of Nephros, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Nephros Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Nephros, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Nephros should always be considered in relation to other companies to make a more educated investment decision.

Nephros Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Nephros' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-08-10
2022-06-30-0.15NoneNone
2022-05-04
2022-03-31-0.11-0.2-0.0981 
2022-02-23
2021-12-31-0.11-0.110
2021-11-04
2021-09-30-0.1-0.12-0.0220 
2021-08-05
2021-06-30-0.11-0.12-0.01
2021-05-06
2021-03-31-0.12-0.060.0650 
2021-03-01
2020-12-31-0.11-0.080.0327 
2020-11-05
2020-09-30-0.14-0.120.0214 
2020-08-05
2020-06-30-0.15-0.19-0.0426 
2020-05-06
2020-03-31-0.08-0.13-0.0562 
2020-02-27
2019-12-31-0.11-0.020.0981 
2019-11-06
2019-09-30-0.1-0.10
2019-08-07
2019-06-30-0.18-0.140.0422 
2019-05-08
2019-03-31-0.09-0.18-0.09100 
2019-03-12
2018-12-31None-0.101None
2018-11-08
2018-09-30None-0.0794None
2018-08-08
2018-06-30None-0.0983None
2018-05-09
2018-03-31None-0.2314None
2018-02-26
2017-12-31None0.2098None
2017-11-09
2017-09-30None-0.1051None
2017-08-08
2017-06-30None-0.1319None
2017-05-09
2017-03-31None-0.1234None
2017-03-20
2016-12-31None-0.1184None
2016-11-10
2016-09-30None-0.1303None
2016-08-15
2016-06-30None-0.1548None
2016-05-12
2016-03-31None-0.1562None
2016-03-30
2015-12-31None-0.1867None
2015-11-11
2015-09-30None-0.1603None
2015-08-10
2015-06-30None-0.1786None
2015-05-12
2015-03-31None-0.1859None
2015-03-19
2014-12-31None-1.555None
2014-11-14
2014-09-30None-0.2518None
2014-08-12
2014-06-30None-0.2339None
2014-05-13
2014-03-31None-0.3635None
2014-03-28
2013-12-31None-0.63None
2013-11-15
2013-09-30None-0.3092None
2013-08-13
2013-06-30None-0.4149None
2013-05-09
2013-03-31None-0.9308None
2013-02-27
2012-12-31None-0.8804None
2012-11-16
2012-09-30None-0.6641None
2012-08-14
2012-06-30None-0.6188None
2012-05-15
2012-03-31None-0.4745None
2012-02-29
2011-12-31None-0.6642None
2011-11-14
2011-09-30None-0.3693None
2011-08-16
2011-06-30None-0.5383None
2011-05-12
2011-03-31None-1.6019None
2011-03-02
2010-12-31None-2.97None
2010-11-12
2010-09-30None-1.6144None
2010-08-17
2010-06-30None-1.5742None
2010-05-13
2010-03-31None-2.2844None
2010-03-03
2009-12-31None-2.1938None
2009-11-13
2009-09-30None-1.7582None
2009-08-17
2009-06-30None-1.9428None
2009-05-14
2009-03-31None-3.4665None
2008-11-17
2008-09-30None-6.3482None
2008-08-14
2008-06-30None-11.5267None
2008-05-15
2008-03-31None-7.7348None
2007-11-14
2007-09-30None-21.3639None
2007-08-14
2007-06-30None-23.8188None
2007-04-10
2007-03-31-34.2-277.221 
2007-02-28
2006-12-31None-32.945None
2006-11-15
2006-09-30-32.4-275.416 
2006-08-22
2006-06-30-28.8-32.4-3.612 
2006-05-22
2006-03-31None-29.9281None
2005-11-14
2005-09-30None-25.564None
2005-08-15
2005-06-30None-29.7306None
2005-05-15
2005-03-31None-5.8201None
2004-11-14
2004-09-30None-699.7977None

About Nephros Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Nephros earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Nephros estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Nephros fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. Nephros operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Nephros without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Anywhere Now

   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Nephros using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Nephros information on this page should be used as a complementary analysis to other Nephros' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Nephros Stock analysis

When running Nephros price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
18.4 M
Quarterly Revenue Growth YOY
-0.2
Return On Assets
-0.2
Return On Equity
-0.37
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine Nephros value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.